Latest News

Seton-Scaffold consortium receive further funding and Bionow award nomination

RegeniTherix™ ability to detect & quantify prognostic biomarkers is highlighted in new publication

Neotherix Strengthens Product Development Team

We are delighted to welcome our new Production Technologist, Daisy Redman.

Daisy will play a key role in the project management of device manufacture and development programmes.

Clare Lankester joins as Technology Programme Manager

Welcome to Dr Clare Lankester as Technology Programme Manager. Clare will have oversight of the Neotherix product portfolio with a view to moving these through appropriate Technology Readiness Levels to commercialisation.

Neotherix will be at Yorkshire Bio-partnering in Bradford

Mike Raxworthy will be attending the Yorkshire Bio-Partnering event at the University of Bradford on 13 April 2022 and will present a talk called “ABC, it’s easy as…..” discussing the importance to Neotherix of collaborations involving academic (A), business (B) and clinical (C) partners. 

Neotherix Shortlisted for the Medilink Healthcare Business Awards

We are delighted to be shortlisted for the Partnership with the NHS: Acute Care Award in the Medilink North of England Healthcare Business Awards 2022!

European patent office logo

RegeniTherix™ Wound Theranostic System EU patent granted

Neotherix is pleased to announce the grant of a European patent 2765921 (“Wound Sampling Device”).

Cafe Economique

Join Mike at Cafe Economique

Dr Mike Raxworthy, the CEO Neotherix, York and Associate Professor, University of Leeds will be speaking about “Yorkshire as a MedTech Innovation Hub”

Join in on this meeting virtually on Tuesday 1st February at 7:30pm using the Zoom meeting link below. 

https://us02web.zoom.us/j/87155832155?pwd=ak1tVXNWRmhyL24ybmcvUW1DRjVGZz09

0122 European Patent

European wound sampling patent

We have been informed that the European Patent Office’s examining division intends to grant a European patent for our wound sampling device.

RegeniTherix™ Wound Theranostic System US patent granted

Neotherix is delighted to announce the grant of US patent 10,687,790 (“Sampling Device”) which covers the critical technology for the RegeniTherix™ device.